Examining a stock’s 52-week price history, encompassing its low and high prices, can reveal much about its existing condition and potential future trajectory. Chromocell Therapeutics Corp.’s current trading price is -88.33% away from its 52-week high, while its distance from the 52-week low is 34.62%. The stock’s price range over this period has fluctuated between $0.52 and $6.00. The company, operating within the financial sector, had a trading volume of approximately 0.82 million for the day, which was noticeably higher than the average daily share volume of 0.11 million over the last 3 months.
Exploring Financial Performance and Market Capitalization: A Comprehensive Analysis
Chromocell Therapeutics Corp. (CHRO) has experienced a quarterly decline of -52.05% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 4.04M and boasts a workforce of 8 employees.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Analyzing Trading Volume and Moving Average Trends
Based on Barchart.com data, the company’s moving average over the 100-day period was 0.9944, with a change in price of -0.6400. Similarly, Chromocell Therapeutics Corp. recorded 87,726 in trading volume during the last 100 days, posting a change of -47.76%.
CHRO Stock Stochastic Average
Today, Chromocell Therapeutics Corp.’s raw stochastic average for the past 50 days stands at 30.51%, indicating a decline from the raw stochastic average of the last 20 days, which was 34.62%. Moreover, the company’s Stochastic %K and %D values over the past 20 days were 30.30% and 30.95% respectively.
CHRO Stock Price Performance Analysis
The stock price performance this year has been a mixed bag, which means people have different opinions about whether it’s been good or bad. Some may see it as optimistic, while others may view it as pessimistic. Year to date metric has recorded a loss of -85.42%.However, over the last six months, we can see a stronger performance of -53.33%. Over the last 30 days, the price of CHRO has leaped by -6.82%. And in the last five days, it has fallen by -9.03%.
